BMP-4 (Mabprex)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBMP-4 (Mabprex)
Drug Alias Namebone morphogenic protein (MabPrex)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMabPrex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabPrex Inc
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A